- ►alphamedpress.org T Wasil, SM Lichtman - The Oncologist, 2005 - AlphaMed Press Persons over the age of 65 years are the fastest growing segment of the US
population. In the next 30 years, they will comprise more than 20% of the
population. Fifty percent of all cancers occur in this age group, and ... Cited by 29 - Related articles - BL Direct - All 10 versions
- ►jcojournal.org K Offit, K Kohut, B Clagett, EA Wadsworth, KJ … - Journal of Clinical Oncology, 2006 - jcojournal.org PURPOSE: Because of increasing uptake of cancer genetic testing and the
improving survival of young patients with cancer, health care practitioners
including oncologists will increasingly be asked about options for assisted ... Cited by 27 - Related articles - All 9 versions
- ►ascopubs.org C Thieblemont, B Coiffier - Journal of Clinical Oncology, 2007 - jco.ascopubs.org One half of patients newly diagnosed with lymphoma are older than 60 years and a
significant proportion of them older than 80 years. Older patients treated for
lymphoma may not tolerate the high-dose therapies used in younger patients, ... Cited by 36 - Related articles - All 6 versions
- ►ascopubs.org TJ Smith, J Khatcheressian, GH Lyman, H Ozer … - Journal of Clinical Oncology, 2006 - jco.ascopubs.org Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
PURPOSE: To update the 2000 American Society of Clinical Oncology guideline ... Cited by 25 - Related articles - All 14 versions
M Mori, K Kitamura, M Masuda, T Hotta, T … - International journal of hematology, 2005 - Springer Page 1. 246 International Journal of HEMATOLOGY 1. Introduction Although
the incidence of non-Hodgkin's lymphoma (NHL) is steadily ... Cited by 19 - Related articles - BL Direct - All 5 versions
A Pinto, R De Filippi, F Frigeri, G Corazzelli … - Critical Reviews in Oncology and Hematology, 2003 - Elsevier While increasing numbers of elderly patients are expected to require
chemotherapy and/or radiotherapy in the future, the application of standard-dose
chemotherapy in unselected cohorts of older patients usually results in a ... Cited by 18 - Related articles - All 3 versions
- ►jcojournal.org DL Hershman, RB McBride, A Eisenberger, … - Journal of Clinical Oncology, 2008 - jcojournal.org Results Of 9,438 patients with DLBCL, 3,164 (42%) received doxorubicin-based
chemotherapy. Any doxorubicin use was associated with a 29% increase in risk of
CHF (95% CI, 1.02 to 1.62); CHF risk increased with number of doxorubicin ... Cited by 14 - Related articles - All 9 versions
L Rigacci, L Nassi, R Alterini, V Carrai, G … - Acta Haematol, 2006 - content.karger.com Background: Aggressive non-Hodgkin's lymphomas (NHL) require intensive therapies
which seemed impracticable in elderly patients. Dose reduction and therapy
attenuation reduced treatment-related toxicity, but also decreased ... Cited by 13 - Related articles - BL Direct - All 5 versions
DP Cronin, LC Harlan, LX Clegg, JL Stevens, … - Hematological Oncology-Chichester, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 12 - Related articles - BL Direct - All 2 versions
E Maartense, HC Kluin-Nelemans, EM … - Annals of Hematology, 2003 - Springer Page 1. Ann Hematol (2003) 82:661–670 DOI 10.1007/s00277-003-0722-1 REVIEW
ARTI CLE E. Maartense · HC Kluin-Nelemans · EM Noordijk ... Cited by 9 - Related articles - BL Direct - All 3 versions
